John G. Gribben, MD, DSc, FRCP, FRCPath, FMed Sci; Barts Cancer Institute, Queen Mary University of London; 5Live; #ASCO2021
4:24
Chronic Lymphocytic Leukemia
John G. Gribben, MD, DSc, FRCP, FRCPath, FMed Sci; Barts Cancer Institute, Queen Mary University of London; 5Live; #ASCO2021
Chronic Lymphocytic Leukemia Similar Videos
Similar Videos
-
Module 3_Treatment Strategies in the Relapsed Refractory Setting_Matthew Davids, MD, MMSc_Jeffrey Bubis, DO, FACOI, FACP_Divis Khaira, MD
11:17
-
Susan O’Brien, MD; University of California Irvine; #DDHO2022
20:24
-
Module 1: Ibrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs_MD_Anthony Mato, MD, MSCE
9:28
